MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2013 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBALSPB |
Anteile |
74.2 M |
Marktkapitalisierung |
$ 2.93 B |
EBITDA (LTM) |
$ -145 M |
P/E (LTM) |
-22.261146 |
P/S (LTM) |
12.9413 |
EPS (LTM) |
-1.57 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
BioXcel Therapeutics
BTAI
|
$ 0.07 | 9.81 % | $ 855 K | Nasdaq Global Select Market,SPB | USA |
 |
InflaRx N.V.
IFRX
|
$ 1.21 | -7.63 % | $ 81.4 M | Nasdaq Global Select Market |  Germany |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
$ 1.78 | 16.33 % | $ 1.2 B | Nasdaq Capital Market |  Israel |
 |
22nd Century Group
XXII
|
$ 1.46 | -10.43 % | $ 269 K | NYSE American | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
$ 4.82 | 2.99 % | $ 780 M | Nasdaq Global Select Market | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
$ 245.39 | 0.76 % | $ 15 B | Nasdaq Global Select Market |  Irlanda |
 |
Zai Lab Limited
ZLAB
|
$ 26.56 | -1.12 % | $ 29.1 B | Nasdaq Global Select Market |  China |
 |
Zentalis Pharmaceuticals
ZNTL
|
$ 1.8 | 3.16 % | $ 129 M | Nasdaq Global Market | USA |
 |
CohBar
CWBR
|
- | -15.44 % | $ 2.2 M | Nasdaq Capital Market | USA |
 |
Zoetis
ZTS
|
$ 82.45 | 0.15 % | $ 36.6 B | NYSE,SPB | USA |
 |
NeuBase Therapeutics
NBSE
|
- | -1.56 % | $ 12.3 M | Nasdaq Global Select Market | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
- | - | $ 2.18 B | Nasdaq Global Select Market,SPB | USA |
 |
Arena Pharmaceuticals
ARNA
|
- | -6.81 % | $ 3.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Scopus BioPharma
SCPS
|
- | -48.37 % | $ 3.71 M | Nasdaq Global Select Market | USA |
 |
Annovis Bio
ANVS
|
$ 0.85 | -5.53 % | $ 17.5 M | NYSE American | USA |
 |
scPharmaceuticals
SCPH
|
- | - | $ 218 M | Nasdaq Global Select Market | USA |
 |
Johnson & Johnson
JNJ
|
$ 281.13 | -0.35 % | $ 677 B | NYSE,SPB | USA |
 |
Kala Pharmaceuticals
KALA
|
$ 0.17 | -2.59 % | $ 1.39 M | Nasdaq Global Select Market | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
- | - | $ 105 M | Nasdaq Global Market | USA |
 |
Athersys
ATHX
|
- | 3.77 % | $ 22.4 M | Nasdaq Capital Market | USA |
 |
Global Blood Therapeutics
GBT
|
- | - | $ 4.62 B | Nasdaq Global Select Market,SPB | USA |
 |
Longeveron
LGVN
|
$ 2.77 | 37.81 % | $ 48.7 B | Nasdaq Global Select Market | USA |
 |
Inozyme Pharma
INZY
|
- | - | $ 207 M | Nasdaq Global Select Market | USA |
 |
MediWound Ltd.
MDWD
|
$ 14.05 | -0.21 % | $ 382 M | Nasdaq Global Select Market | Israel |
 |
Idera Pharmaceuticals
IDRA
|
- | -23.04 % | $ 26.6 M | Nasdaq Global Select Market | USA |
 |
Mirum Pharmaceuticals
MIRM
|
$ 94.4 | 1.31 % | $ 4.74 B | Nasdaq Global Select Market | USA |
 |
NanoString Technologies
NSTG
|
- | -37.43 % | $ 5.1 M | Nasdaq Global Select Market | USA |
 |
Humanigen
HGEN
|
- | -81.12 % | $ 4.28 M | Nasdaq Global Select Market | USA |
 |
Sorrento Therapeutics
SRNE
|
- | -29.58 % | $ 126 M | Nasdaq Global Select Market | USA |
 |
Surface Oncology
SURF
|
- | - | $ 59.7 M | Nasdaq Global Select Market | USA |
 |
Sierra Oncology
SRRA
|
- | -0.05 % | $ 1.34 B | Nasdaq Global Select Market |  Canada |
 |
Cocrystal Pharma
COCP
|
$ 1.03 | -6.33 % | $ 11.6 M | Nasdaq Capital Market | USA |
 |
Atea Pharmaceuticals
AVIR
|
$ 4.24 | -3.97 % | $ 346 M | Nasdaq Global Select Market | USA |
 |
Nektar Therapeutics
NKTR
|
$ 37.82 | -0.01 % | $ 638 M | Nasdaq Global Select Market,SPB | USA |
 |
Vaccinex
VCNX
|
- | -61.37 % | $ 654 K | Nasdaq Global Select Market | USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
- | -19.68 % | $ 18.4 M | Nasdaq Capital Market | Canada |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Lineage Cell Therapeutics
LCTX
|
$ 1.05 | -3.24 % | $ 242 M | NYSE American | USA |
 |
Jounce Therapeutics
JNCE
|
- | - | $ 98.4 M | Nasdaq Global Select Market | USA |
 |
Verona Pharma plc
VRNA
|
- | - | $ 69.7 B | Nasdaq Global Select Market |  Britain |
 |
Corner Growth Acquisition Corp.
COOL
|
- | -0.89 % | $ 114 M | Nasdaq Global Select Market | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Akari Therapeutics, Plc
AKTX
|
$ 7.0 | -8.62 % | $ 471 B | Nasdaq Capital Market | Britain |
 |
Mersana Therapeutics
MRSN
|
- | - | $ 3.56 B | Nasdaq Global Select Market | USA |
 |
CymaBay Therapeutics
CBAY
|
- | - | $ 3.45 B | Nasdaq Global Select Market | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
- | - | $ 384 M | Nasdaq Global Select Market | Britain |
 |
Genmab A/S
GMAB
|
$ 54.08 | -3.08 % | $ 3.5 B | Nasdaq Global Select Market |  Danmark |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
Timber Pharmaceuticals
TMBR
|
- | - | $ 717 K | NYSE American | USA |